Item Type | Name |
Concept
|
Diabetes Mellitus, Experimental
|
Concept
|
Renal Dialysis
|
Concept
|
Melanoma, Experimental
|
Concept
|
Pathology
|
Concept
|
Renal Circulation
|
Concept
|
Liver Neoplasms, Experimental
|
Concept
|
Neoplasms, Experimental
|
Concept
|
Myasthenia Gravis, Autoimmune, Experimental
|
Concept
|
Renal Plasma Flow, Effective
|
Concept
|
Renal Insufficiency
|
Academic Article
|
Tacrolimus rescue therapy for renal transplant rejection.
|
Academic Article
|
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface.
|
Academic Article
|
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.
|
Academic Article
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Academic Article
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Academic Article
|
The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system.
|
Academic Article
|
I-131 orthoiodohippurate assessment of renal function after heart transplantation.
|
Academic Article
|
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.
|
Academic Article
|
Tacrolimus in renal transplantation.
|
Academic Article
|
Changes in renal function after liver transplantation under FK 506.
|
Academic Article
|
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
|
Academic Article
|
Real-time monitoring of acute liver-allograft rejection using the Banff schema.
|
Academic Article
|
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
|
Academic Article
|
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.
|
Academic Article
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Academic Article
|
ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation.
|
Academic Article
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Academic Article
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Academic Article
|
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation.
|
Academic Article
|
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Academic Article
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Academic Article
|
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
|
Academic Article
|
The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes.
|
Academic Article
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Academic Article
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
|
Academic Article
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Quantitative assessment of the development of hepatoma in a buffalo rat model.
|
Academic Article
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Academic Article
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Academic Article
|
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
|
Academic Article
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Academic Article
|
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
|
Academic Article
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
Academic Article
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Academic Article
|
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
|
Academic Article
|
Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis.
|
Academic Article
|
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.
|
Academic Article
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
Academic Article
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Academic Article
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
|
Academic Article
|
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
|
Academic Article
|
Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis.
|
Academic Article
|
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
|
Academic Article
|
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.
|
Academic Article
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Academic Article
|
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
|
Academic Article
|
Renal transplantation in recipients over the age of 60: the impact of donor age.
|
Academic Article
|
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.
|
Academic Article
|
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.
|
Academic Article
|
Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.
|
Academic Article
|
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
|
Academic Article
|
Limitations of current liver transplant immunosuppressive regimens: renal considerations.
|
Academic Article
|
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
|
Academic Article
|
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression.
|
Academic Article
|
Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression.
|
Grant
|
ORTHOTOPIC LIVER TRANSPLANTATION
|
Academic Article
|
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial.
|